This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignees: Nature's Plus Farmacêutica Ltda., Sigma Pharma Ltda.. Active years: 2011-2012.
Location History:
- Hortolandia, BR (2011)
- Hortolândia, BR (2012)
Company Filing History:
Years Active: 2011-2012
Title: Carlo Oliani: Innovator in Pharmaceutical Compositions
Introduction
Carlo Oliani is a notable inventor based in Hortolândia, Brazil. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for sublingual administration. With a total of 2 patents, his work focuses on enhancing the efficacy of pharmaceutical compounds.
Latest Patents
One of Oliani's latest patents is a pharmaceutical composition based on an agonist of benzodiazepine. This invention describes the use of pharmaceutical compounds for sublingual administration, incorporating active ingredients such as diazepam, lorazepam, and others. The formulation consists of a mixture with at least 70% of the weight being a pharmaceutical excipient, including lactose, sorbitol, and cellulose.
Another significant patent is related to sublingual formulations of ketorolac or its pharmaceutically acceptable salts. This invention aims to accelerate the pharmacological response to ketorolac without the need for injectable methods. The composition includes ketorolac as an active principle, representing 10 to 15% by weight, combined with a ternary mixture of lactose, sorbitol, and cellulose.
Career Highlights
Throughout his career, Carlo Oliani has worked with reputable companies such as Sigma Pharma Ltda. and Nature's Plus Farmacêutica Ltda. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Oliani has collaborated with notable professionals in the field, including Guido Vandoni and Adriano Coelho. These partnerships have likely enriched his research and development efforts.
Conclusion
Carlo Oliani's contributions to pharmaceutical compositions demonstrate his commitment to innovation in the healthcare sector. His patents reflect a deep understanding of drug formulation and administration, paving the way for advancements in patient care.